IP Library Granted Patent US 12,089,891
Granted Patent B2
US 12,089,891 · App. 17/473,408 · Granted Sep 17, 2024

Multi-use endocardial ablation catheter

Inventor: Josef Koblish (Sunnyvale, CA)
Assignee: Pfix, Inc.
A61B18/1492A61B2018/00351A61B2018/00357A61B2018/00375A61B2018/00577A61B2018/00601A61B2018/00642A61B2018/00702A61B2018/00708A61B2018/00779A61B2018/00922A61B18/14A61B2018/1405A61B2018/1407A61B18/24
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,089,891
App. No.
17/473,408
Granted
Sep 17, 2024
Kind
B2
Abstract

A method comprises introducing an ablation catheter assembly into a heart chamber of the patient, deploying an ablative loop structure from an elongated shaft of the ablation catheter assembly, placing the ablative loop structure in an expanded geometry, disposing the expanded ablative loop structure on the endocardial tissue around an ostium of a blood vessel extending from the heart chamber, activating the ablative loop structure, thereby creating a circumferential lesion around the ostium of the blood vessel, disposing the ablative shaft distal end, when the ablative loop structure is housed within the elongated shaft, at a target region of the endocardial tissue remote from the ostium of the blood vessel, and activating the ablative shaft distal end, thereby creating another lesion at the target region.

Claims (16)

1. A method of ablating endocardial tissue of a patient using an ablation catheter assembly having an elongated shaft having an ablative shaft distal end comprising at least one ablative element and a distal tip port distal to the at least one ablative element, and an ablative loop structure housed within the elongated shaft, the method comprising:

introducing the ablation catheter assembly into a heart chamber of the patient while the ablative loop structure is housed within the elongated shaft;

deploying the ablative loop structure from the elongated shaft via the distal tip port;

placing the ablative loop structure in an expanded geometry;

disposing the expanded ablative loop structure on the endocardial tissue around an ostium of a blood vessel extending from the heart chamber;

activating the ablative loop structure, thereby creating a circumferential lesion around the ostium of the blood vessel;

disposing the at least one ablative element, when the ablative loop structure is housed within the elongated shaft, at a target region of the endocardial tissue remote from the ostium of the blood vessel; and

activating the at least one ablative element, thereby creating another lesion at the target region.

2. The method of claim 1 , wherein the ablative loop structure assumes the expanded geometry in response to deploying the ablative loop structure from the elongated shaft.

3. The method of claim 1 , wherein the heart chamber is a left atrium, and the blood vessel is a pulmonary vein.

4. The method of claim 1 , further comprising retracting the ablative loop structure within the elongated shaft via the distal tip port after creating the circumferential lesion around the ostium of the blood vessel, but prior to disposing the at least one ablative element at the target site of the endocardial tissue.

5. The method of claim 1 , wherein the target region is a target line.

6. The method of claim 5 , wherein disposing the at least one ablative element at the target region of the endocardial tissue and activating the at least one ablative element comprises iteratively disposing a single one of the at least one ablative element at different points along the target line of the endocardial tissue and activating the single one of the at least one ablative element, thereby iteratively creating the other lesion along the target line.

7. The method of claim 5 , wherein the ablative shaft distal end comprises a linear array of ablative elements, and wherein disposing the at least one ablative element at the target region of the endocardial tissue and activating the at least one ablative element comprises disposing the linear array of ablative elements along the target line of the endocardial tissue and activating the the linear array ablative elements, thereby creating the other lesion along the target line.

8. The method of claim 1 , wherein the patient has a cardiac arrhythmia, and the circumferential lesion and other lesion treats the cardiac arrhythmia.

9. The method of claim 1 , wherein the ablation catheter assembly is introduced into the heart chamber of the patient via a vasculature of the patient.

Assignments (4)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 14, 2026
From: CORTEX, INC.
To: BOSTON SCIENTIFIC SCIMED, INC.
Reel/Frame 073468/0615 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 4, 2024
From: PFIX INC.
To: ABLACON INC.
Reel/Frame 068486/0283 →
MERGER Recorded Sep 4, 2024
From: ABLACON INC.
To: CORTEX, INC.
Reel/Frame 068486/0427 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 24, 2024
From: KOBLISH, JOSEF
To: PFIX, INC.
Reel/Frame 066235/0046 →